The FDA approves Amgen's biosimilar version of Humira

Amgen's drug is set to compete with AbbVie's Humira, which is the second-best selling drug in the U.S. in 2015.

The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study

The Michael J. Fox Foundation uses Facebook to recruit Ashkenazi Jews for Parkinson's study

The organization said it used Facebook to identify participants for a study designed to identify biomarkers associated with Parkinson's disease.

McCann Health forms new global consultancy

McCann Health forms new global consultancy

The consultancy includes Double Helix, which was acquired by McCann in 2012.

Ogilvy's Michael Johnston on Using the Familiar in Diabetes Ads

Ogilvy's Michael Johnston on Using the Familiar in Diabetes Ads

The science behind new diabetes drugs underscores how far we've come from the days of purified pork insulin. Even so, most ads stick to traditional copy.

Five things for pharma marketers to know: Friday, September 23, 2016

Five things for pharma marketers to know: Friday, September 23, 2016

Anthem and Cigna accuse each other of violating merger terms; Alzheimer's experimental drug fails late-stage study; study calls for new approach to eradicate global epidemics

Five things for pharma marketers to know: Thursday, September 22, 2016

Five things for pharma marketers to know: Thursday, September 22, 2016

Mylan CEO comes under fire at House Committee hearing; Abbott OxyContin reps went to great lengths to sell the pain pill; UnitedHealth drops Lantus

Five things for pharma marketers to know: Wednesday, September 21, 2016

Five things for pharma marketers to know: Wednesday, September 21, 2016

Drugmakers to remove incentives for sales reps marketing antibiotics; Mylan CEO defends EpiPen pricing; fitness trackers don't help people lose weight

Campaign seeks to educate doctors about when to prescribe opioids

Campaign seeks to educate doctors about when to prescribe opioids

Some physicians say they believe they have a responsibility to address the opioid epidemic, but misinformation may hinder them in that pursuit.

WebMD CEO departs, replaced by president

WebMD CEO departs, replaced by president

WebMD said David Schlanger left the company under mutual agreement, and that Steven Zatz replaced him as CEO.

Ascension begins hospital-rebranding push

Ascension begins hospital-rebranding push

Ascension worked with several Omnicom agencies on the rebranding push, including FleishmanHillard and Siegel & Gale.

Five things for pharma marketers to know: Tuesday, September 20, 2016

Five things for pharma marketers to know: Tuesday, September 20, 2016

GSK names new CEO; the FDA approves first Duchenne muscular dystrophy drug; Sanofi files Lantus patent lawsuit against Merck

Alexion uses superheroes, social media to raise rare-disease awareness

Alexion uses superheroes, social media to raise rare-disease awareness

Alexion launched a new superhero-themed awareness campaign to draw attention to four rare diseases that its products treat.

Five things for pharma marketers to know: Monday, September 19, 2016

Five things for pharma marketers to know: Monday, September 19, 2016

Some U.S. hospitals still haven't received Valeant discounts; U.N. General Assembly will discuss antibiotic resistance; AstraZeneca diabetes drugs lowered blood sugar in study

Q&A: Cardiogram's Ballinger on using the Apple Watch to track heart rate

Q&A: Cardiogram's Ballinger on using the Apple Watch to track heart rate

The app's co-founder discusses how it's educating patients and physicians about artificial intelligence and why Cardiogram is different from other heart-rate tracking apps.

Agency Spotlight


OPINION

Email Newsletters